Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...

Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Journal of Allergy and ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the European Union based on earlier trial readouts. Outside of Japan and the UAE, ...

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

In hospitalized patients, eosinophil levels positively correlated with antibiotic use, systemic inflammation, and worsened ...

UVA Health has found that eosinophilic esophagitis, once considered a rare allergic condition, is increasingly being ...

The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.

Have you ever felt a tightness in your chest or struggled to catch your breath during a workout? You might be experiencing exercise-induced asthma (EIA), a common condition that affects both seasoned ...